Stanford University genetics professor Dr. Stanley Cohen paid $29.2 million to settle a lawsuit over misleading claims he made about Nuredis Inc., his now-dissolved biotechnology company.

A prominent genetics professor at Stanford University in the US has paid $29 million to investors in Nuredis – a biotech that has now been wound up – after a California court found he ...

Biotechnology has enormous potential to solve ... Before founding TeselaGen, Mike Fero, Nathan Hillson, and Abeliuk were working at Stanford University, spending a lot of time on tasks that ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.

The broad field of biotechnology and applied microbiology covers topics on the manipulation of living organisms to make products or solve problems to meet human needs. Students in this field study ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped by a confluence of factors, all of which are driving exciting innovations ...

After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...

Diag-Nose.io hopes to transform management of chronic respiratory diseases globally using its AI-powered biomarker diagnostic ...

Director of the US-Asia Technology Management Center at Stanford University; Marietta Wu, Managing Director of Quan Capital; and Mika Nishimura, Operational Partner of Glide Healthcare. Dr. Kelly ...